Atopic dermatitis

Update for pediatricians

Katherine Grey, Sheilagh Maguiness

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder present in up to 20% of children. Recent advances implicate skin barrier dysfunction as central to disease pathogenesis. Genetic defects in the filaggrin gene, the product of which is important for maintaining the epidermal barrier, are a strong predisposing factor in the development of AD. In addition to reducing identifiable triggers, treatment should focus on the four clinical characteristics of eczema: emollients for dry skin, topical anti-inflammatory agents to reduce inflammation and itch, and strategies to reduce infection/colonization, which can include diluted bleach baths. New studies demonstrate that early emollient application from birth may prevent development of AD.

Original languageEnglish (US)
Pages (from-to)e280-e286
JournalPediatric Annals
Volume45
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Atopic Dermatitis
Emollients
Skin
Eczema
Baths
Causality
Anti-Inflammatory Agents
Parturition
Inflammation
Infection
Genes
Pediatricians
Therapeutics

Cite this

Atopic dermatitis : Update for pediatricians. / Grey, Katherine; Maguiness, Sheilagh.

In: Pediatric Annals, Vol. 45, No. 8, 01.08.2016, p. e280-e286.

Research output: Contribution to journalArticle

Grey, Katherine ; Maguiness, Sheilagh. / Atopic dermatitis : Update for pediatricians. In: Pediatric Annals. 2016 ; Vol. 45, No. 8. pp. e280-e286.
@article{780ab07d84e646b4a8ca3ee2febdc25f,
title = "Atopic dermatitis: Update for pediatricians",
abstract = "Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder present in up to 20{\%} of children. Recent advances implicate skin barrier dysfunction as central to disease pathogenesis. Genetic defects in the filaggrin gene, the product of which is important for maintaining the epidermal barrier, are a strong predisposing factor in the development of AD. In addition to reducing identifiable triggers, treatment should focus on the four clinical characteristics of eczema: emollients for dry skin, topical anti-inflammatory agents to reduce inflammation and itch, and strategies to reduce infection/colonization, which can include diluted bleach baths. New studies demonstrate that early emollient application from birth may prevent development of AD.",
author = "Katherine Grey and Sheilagh Maguiness",
year = "2016",
month = "8",
day = "1",
doi = "10.3928/19382359-20160720-05",
language = "English (US)",
volume = "45",
pages = "e280--e286",
journal = "Pediatric Annals",
issn = "0090-4481",
publisher = "Slack Incorporated",
number = "8",

}

TY - JOUR

T1 - Atopic dermatitis

T2 - Update for pediatricians

AU - Grey, Katherine

AU - Maguiness, Sheilagh

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder present in up to 20% of children. Recent advances implicate skin barrier dysfunction as central to disease pathogenesis. Genetic defects in the filaggrin gene, the product of which is important for maintaining the epidermal barrier, are a strong predisposing factor in the development of AD. In addition to reducing identifiable triggers, treatment should focus on the four clinical characteristics of eczema: emollients for dry skin, topical anti-inflammatory agents to reduce inflammation and itch, and strategies to reduce infection/colonization, which can include diluted bleach baths. New studies demonstrate that early emollient application from birth may prevent development of AD.

AB - Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder present in up to 20% of children. Recent advances implicate skin barrier dysfunction as central to disease pathogenesis. Genetic defects in the filaggrin gene, the product of which is important for maintaining the epidermal barrier, are a strong predisposing factor in the development of AD. In addition to reducing identifiable triggers, treatment should focus on the four clinical characteristics of eczema: emollients for dry skin, topical anti-inflammatory agents to reduce inflammation and itch, and strategies to reduce infection/colonization, which can include diluted bleach baths. New studies demonstrate that early emollient application from birth may prevent development of AD.

UR - http://www.scopus.com/inward/record.url?scp=84988664258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988664258&partnerID=8YFLogxK

U2 - 10.3928/19382359-20160720-05

DO - 10.3928/19382359-20160720-05

M3 - Article

VL - 45

SP - e280-e286

JO - Pediatric Annals

JF - Pediatric Annals

SN - 0090-4481

IS - 8

ER -